Delivery Order SPE2DB20D3303-SPE2DB23FZ4R2
Award Date
4/27/23
Potential Completion Date
4/28/23
Potential Value
$7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablet units to the Defense Logistics Agency (DLA). The $1,057 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award has an ultimate completion date of March 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award is for the supply of Micardis HCT 80-25 mg tablets by Amerisourcebergen Drug Corp to the Defense Logistics Agency (DLA). The $2,463.75 firm fixed-price delivery order has a completion date of July 25, 2024. The contract is not set aside for any special designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, including a $999,999,999 IDC with the DLA Troop...
This federal contract award is for the delivery of Micardis HCT 80-12.5 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,346.30 and a final completion date of December 5, 2023. It is a delivery order contract with a firm fixed price pricing type. This contract is not designated with any set-aside requirements,...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablet units to the Defense Logistics Agency (DLA), a defense agency. The $1,666.42 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 22, 2023, with a completion date of May 23, 2023. This contract is a delivery order under a larger $999,999,999 indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablet units to the Defense Logistics Agency (DLA), a defense agency. The $2,865.39 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a performance period running through February 15, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,074.50 and an ultimate completion date of May 7, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $21,376.80, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a firm fixed-price delivery order with a period of performance through September 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999,...
This federal contract award is for the delivery of Micardis HCT 40-12.5 mg tablet products to the Defense Logistics Agency (DLA). The contract, valued at $2,067.49, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. Amerisourcebergen is a major pharmaceutical distributor with significant experience in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The contract is a...
This federal contract award is for the delivery of Micardis HCT 80-25 mg tablets to the Defense Logistics Agency (DLA). The $3,546.28 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $1,556.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Micardis HCT 80-25 mg tablet units, with a completion date of May 7, 2024. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is the prime contractor for this delivery order. The contract type is Firm Fixed Price, and it is not...